TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07178210: Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

Sponsor: MMI (Medical Microinstruments, Inc.) · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 20 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$853,600

Rescue Site Savings

+$582,000

Unlock Full NCT07178210 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07178210 Rescue Dossier →